Annual Drug Patent Expirations for SYNDROS
Syndros is a drug marketed by Benuvia and is included in one NDA. There are three patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for SYNDROS.
This drug has four patent family members in four countries.
The generic ingredient in SYNDROS is dronabinol. Additional details are available on the dronabinol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
